NSDHL
Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating
Also known as: H105e3, NSDHL_HUMAN, SDR31E1, XAP104
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15738
- Gene
- NSDHL
- Ensembl
- ENSG00000147383
- Chromosome
- X
- Canonical length
- 373 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Lipid droplets
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
373 residues, UniProt reviewed canonical sequence.
>Q15738|NSDHL
1 MEPAVSEPMR DQVARTHLTE DTPKVNADIE KVNQNQAKRC TVIGGSGFLG QHMVEQLLAR
61 GYAVNVFDIQ QGFDNPQVRF FLGDLCSRQD LYPALKGVNT VFHCASPPPS SNNKELFYRV
121 NYIGTKNVIE TCKEAGVQKL ILTSSASVIF EGVDIKNGTE DLPYAMKPID YYTETKILQE
181 RAVLGANDPE KNFLTTAIRP HGIFGPRDPQ LVPILIEAAR NGKMKFVIGN GKNLVDFTFV
241 ENVVHGHILA AEQLSRDSTL GGKAFHITND EPIPFWTFLS RILTGLNYEA PKYHIPYWVA
301 YYLALLLSLL VMVISPVIQL QPTFTPMRVA LAGTFHYYSC ERAKKAMGYQ PLVTMDDAME
361 RTVQSFRHLR RVKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NSDHL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 50 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 50 nTPM
- liver: 47 nTPM
- epididymis: 42 nTPM
- adrenal gland: 37 nTPM
- small intestine: 24 nTPM
- vagina: 23 nTPM
Single-cell type
- esophageal apical cells: 239 nCPM
- oocytes: 147 nCPM
- epididymal principal cells: 144 nCPM
- esophageal suprabasal cells: 95 nCPM
- breast lactating cells: 71 nCPM
- esophageal basal cells: 54 nCPM
Immune cell
- basophil: 21 nTPM
- T-reg: 20 nTPM
- NK-cell: 20 nTPM
- classical monocyte: 20 nTPM
- myeloid DC: 19 nTPM
- memory B-cell: 19 nTPM
Brain region
- pons: 27 nTPM
- midbrain: 20 nTPM
- medulla oblongata: 20 nTPM
- thalamus: 19 nTPM
- white matter: 19 nTPM
- hypothalamus: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NSDHL.
Disease | AllUniProt
Conditions NSDHL is implicated in, by any mechanism.
- Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) MIM:308050
- CK syndrome (CKS) MIM:300831
Disease | GeneticClinVar
20 pathogenic / likely-pathogenic of 314 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Child syndrome
- CK syndrome
- Thyroid cancer, nonmedullary, 1
- Malignant tumor of urinary bladder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 0.87
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol biosynthetic process
- cholesterol biosynthetic process via lathosterol
- cholesterol metabolic process
- hair follicle development
- labyrinthine layer blood vessel development
- smoothened signaling pathway
Molecular functions
- 3-beta-hydroxy-Delta5-steroid dehydrogenase (NAD+) activity
- oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
- 3-beta-hydroxysteroid dehydrogenase (NAD+)/C4-decarboxylase activity
- 3-beta-hydroxysteroid dehydrogenase [NAD(P)+]/C4-decarboxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
- Acetylation
- Cholesterol biosynthesis
- Cholesterol metabolism
- Endoplasmic reticulum
- Ichthyosis
- Intellectual disability
- Lipid biosynthesis
- Lipid droplet
- Lipid metabolism
- Membrane
- NAD
- Oxidoreductase
- Phosphoprotein
- Steroid biosynthesis
- Steroid metabolism
- Sterol biosynthesis
- Sterol metabolism
- Transmembrane
- Transmembrane helix
InteractionsUniProt · HPA
Protein binding partners of NSDHL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NSDHL as an antibody target. Whether an autoantibody or antibody against NSDHL could matter depends on whether native NSDHL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NSDHL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NSDHL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...